Overview
Serine is a non-essential, polar amino acid that plays a central role in protein synthesis and cellular metabolism. It contains a reactive hydroxyl group, which makes it important in enzyme active sites and protein modification processes such as phosphorylation and glycosylation.
Serine acts as a crucial metabolic hub, linking glycolysis with one-carbon metabolism, folate pathways, and the methionine cycle. It is synthesized endogenously from glycolytic intermediates, mainly 3-phosphoglycerate, and contributes one-carbon units required for DNA, RNA, and nucleotide biosynthesis. Serine exists in multiple biological forms, including L-serine, which supports cell growth, and D-serine, which functions as a neuromodulator in the central nervous system.
Symptoms
Imbalance in serine levels mainly affects the neurological, developmental, metabolic, and peripheral nervous systems. Excess serine may be associated with seizures, hyperserinemia, renal tubular toxicity, hepatic stress, peripheral neuropathy, and developmental abnormalities such as microcephaly.
Neurological manifestations are linked to altered neurotransmission and NMDA receptor modulation. Serine deficiency presents with seizures, microcephaly, psychomotor retardation, hypotonia or spastic quadriplegia, polyneuropathy, cataracts in severe infantile cases, and impaired brain development. These symptoms reflect serine’s essential role in neuroprotection, neurotransmitter balance, and membrane synthesis.
Causes
Abnormal serine levels arise from genetic, metabolic, or secondary disease processes. Congenital serine biosynthesis defects, such as deficiencies of phosphoglycerate dehydrogenase, phosphoserine aminotransferase, or phosphoserine phosphatase, lead to low serine levels, especially in the central nervous system. Elevated serine levels occur in hyperserinemia due to enzyme accumulation or impaired metabolism.
Liver dysfunction, renal impairment, and disruption of one-carbon metabolism can also alter serine balance. Secondary disturbances may occur in mitochondrial disorders and conditions affecting folate or methionine cycles.
Risk Factors
Risk factors for abnormal serine metabolism include inherited metabolic disorders, neonatal and pediatric age groups, liver disease, renal tubular dysfunction, chronic illness, and nutritional imbalance. Newborns are particularly vulnerable, which is why serine is included in newborn amino acid screening panels.
Patients with unexplained seizures, developmental delay, microcephaly, or peripheral neuropathy are at higher risk of underlying serine metabolism disorders. Improper sample collection, delayed processing, and lack of fasting can also affect laboratory interpretation of serine levels.
Prevention
Prevention focuses on early detection, accurate laboratory testing, and management of underlying metabolic conditions. Newborn screening allows early identification of congenital serine deficiency disorders and helps prevent irreversible neurological damage. Adequate nutritional support and timely supplementation in confirmed deficiency improve neurological and developmental outcomes.
Proper sample collection, rapid processing, cooling, and correct storage of plasma, CSF, urine, or dried blood spot samples improve diagnostic accuracy. Early diagnosis and appropriate metabolic management help maintain normal serine balance and prevent long-term complications.
